Evidence map›Paper›PMID 31660661›Full record

ArticleHuman mutation2020

Recurrent TTN metatranscript-only c.39974-11T>G splice variant associated with autosomal recessive arthrogryposis multiplex congenita and myopathy.

Samantha J Bryen, Lisa J Ewans, Jason Pinner, Suzanna C MacLennan, Sandra Donkervoort, Diana Castro, Ana Töpf, Gina O'Grady, Beryl Cummings, Katherine R Chao and 25 more

Abstract read
In one paragraph

Article in Human mutation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Phenotype-specific muscle proteomic profiling in titinopathies.Acta neuropathologica communications · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Congenital Titinopathies Linked to Mutations inInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Bi-allelic loss-of-function variants inJournal of medical genetics · 2023
    Article
  20. Use of animal models to understand titin physiology and pathology.Journal of cellular and molecular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Samantha J BryenKids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.ORCID 0000-0002-4140-8622
Lisa J EwansDepartment of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Jason PinnerDepartment of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
Suzanna C MacLennanNeurology Department, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
Sandra DonkervoortNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Diana CastroDepartment of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas.
Ana TöpfJohn Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Gina O'GradyKids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.
Beryl CummingsAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Katherine R ChaoAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Ben WeisburdAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Laurent FrancioliAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Fathimath FaizDepartment of Diagnostic Genomics, PathWest Laboratory Medicine, Nedlands, WA, Australia.
Adam M BournazosKids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.ORCID 0000-0002-6464-4548
Ying HuNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Carla GrosmannDepartment of Neurology, Rady Children's Hospital University of California San Diego, San Diego, California.
Denise M MalickiDepartment of Pathology, Rady Children's Hospital University of California San Diego, San Diego, California.
Helen DoyleDepartment of Histopathology, The Children's Hospital at Westmead, Sydney Children's Hospital Network, Westmead, NSW, Australia.
Nanna WittingCopenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
John VissingCopenhagen Neuromuscular Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Kristl G ClaeysDepartment of Neurology, University Hospitals Leuven, Leuven, Belgium.
Kathryn UrankarDepartment of Neuropathology, Southmead Hospital, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Ana Beleza-MeirelesClinical Genetics, Bristol Royal Hospital For Children, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Julia BaptistaMolecular Genetics Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.
Sian EllardMolecular Genetics Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, United Kingdom.
Marco SavareseFolkhälsan Research Center, Medicum, University of Helsinki, Haartmaninkatu 8, Helsinki, 00290, Finland.
Mridul JohariFolkhälsan Research Center, Medicum, University of Helsinki, Haartmaninkatu 8, Helsinki, 00290, Finland.
Anna ViholaFolkhälsan Research Center, Medicum, University of Helsinki, Haartmaninkatu 8, Helsinki, 00290, Finland.
Bjarne UddFolkhälsan Research Center, Medicum, University of Helsinki, Haartmaninkatu 8, Helsinki, 00290, Finland.
Anirban MajumdarPaediatric Neurology, Bristol Royal Hospital For Children, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
Volker StraubJohn Walton Muscular Dystrophy Research Centre, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
Carsten G BönnemannNeurogenetics Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.
Daniel G MacArthurAnalytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts.
Mark R DavisDepartment of Diagnostic Genomics, PathWest Laboratory Medicine, Nedlands, WA, Australia.
Sandra T CooperKids Neuroscience Centre, Kids Research, Children's Hospital at Westmead, Westmead, New South Wales, Australia.ORCID 0000-0002-7314-5097

Funding

Molecular and Clinical Manifestations of Matrix and Aggregate MyopathiesZIANS003129 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI BÖNNEMANN, CARSTEN · 2011 to 2025
$52.8M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
REGULATORY GENE INDUCTION BY ACTIVITY IN VISUAL CORTEXR01EY008900 · NEI · JOHNS HOPKINS UNIVERSITY · PI WORLEY, PAUL F · 1991 to 1993
–
NHGRI NIH HHS UM1 HG008900
6 · The paper itself

Abstract

We present eight families with arthrogryposis multiplex congenita and myopathy bearing a TTN intron 213 extended splice-site variant (NM_001267550.1:c.39974-11T>G), inherited in trans with a second pathogenic TTN variant. Muscle-derived RNA studies of three individuals confirmed mis-splicing induced by the c.39974-11T>G variant; in-frame exon 214 skipping or use of a cryptic 3' splice-site effecting a frameshift. Confounding interpretation of pathogenicity is the absence of exons 213-217 within the described skeletal muscle TTN N2A isoform. However, RNA-sequencing from 365 adult human gastrocnemius samples revealed that 56% specimens predominantly include exons 213-217 in TTN transcripts (inclusion rate ≥66%). Further, RNA-sequencing of five fetal muscle samples confirmed that 4/5 specimens predominantly include exons 213-217 (fifth sample inclusion rate 57%). Contractures improved significantly with age for four individuals, which may be linked to decreased expression of pathogenic fetal transcripts. Our study extends emerging evidence supporting a vital developmental role for TTN isoforms containing metatranscript-only exons.

Indexed as

Alternative SplicingGenes, RecessiveGenetic Predisposition to DiseaseArthrogryposisChildChild, PreschoolConnectinFemaleGenetic Association StudiesHumansInfantMaleMuscular DiseasesMutationPedigreePhenotypeConnectinTTN protein, humanalternative splicingarthrogryposiscongenital titinopathiesintronic splice variantTTN metatranscript-only

Identifiers

PMID31660661
PMCPMC7306402

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.